In our patient, a history of past migraines and atypical stroke symptoms with an initial NIHSS score of 2 led us to avoid recommending tissue-type plasminogen activator therapy, which may have mitigated her progressive thalamic symptoms. This evidence concerns the gene PLAT and Stroke.